Aprotinin versus lysine analogues: the debate continues.

Aprotinin versus lysine analogues: the debate continues.

Item
http://www.wikidata.org/entity/Q41752154
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusionPharmacological approaches to reducing allogeneic blood exposure.Modulation of systemic inflammatory response after cardiac surgery.Safety aspects of aprotinin therapy in cardiac surgery patients.Postoperative intracranial haemorrhage: a review.Natural and engineered plasmin inhibitors: applications and design strategies.The current place of aprotinin in the management of bleeding.Management of the Jehovah's Witness in Obstetrics and Gynecology: A Comprehensive Medical, Ethical, and Legal Approach.The fibrinolytic system attenuates vascular tone: effects of tissue plasminogen activator (tPA) and aminocaproic acid on renal microcirculation.Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.
P2860

Aprotinin versus lysine analogues: the debate continues.

Item
http://www.wikidata.org/entity/Q41752154
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Aprotinin versus lysine analogues: the debate continues.
@en
type
label
Aprotinin versus lysine analogues: the debate continues.
@en
prefLabel
Aprotinin versus lysine analogues: the debate continues.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Aprotinin versus lysine analogues: the debate continues.
@en
P2093
P304
P31
P356
10.1016/S0003-4975(98)00071-X
P407
P433
P478
P577
P698